Notice: Prescription Drug List (PDL): Vitamin D (English, HTML)
View metadata and access the original English HTML file: Notice: Prescription Drug List (PDL): Vitamin D.
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2023-09-30
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D on the Prescription Drug List (PDL) to allow non-prescription status for products a) containing up to 62.5 µg or 2,500 International Units (IU)/dosage form for oral use; or b) with a maximum recommended daily oral intake of 2,500 IU. Only the Human part of the PDL was revised.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file